Somatic variants were rarely identified with VAFs >=10% in nail samples and were primarily confined to disease-defining alterations associated with loss of heterozygosity (LOH) in the tumor sample, such as JAK2 and TET2 in myeloproliferative neoplasms. Here, JAK2 is linked to myeloproliferative neoplasm.